ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a proprietary brain shuttle, for alpha-synucleinopathies, including Parkinson’s disease ABL301 uses ABL’s Grabody-B platform technology to effectively cross the blood-brain barrier
كوانزو، الصين، 12 يناير 2022 /PRNewswire/ — في إطار فعاليات «أسبوع غوانغدونغ» التي ستُعقد في جناح الصين في معرض «إكسبو 2020 دبي»، ستنطلق فعاليات معرض (الإمارات – غوانغدونغ) في 11 يناير 2022، لعرض منتجات الشركات العاملة في مقاطعة غوانغدونغ افتراضيًا من خلال بث مباشر عبر الإنترنت، بمشاركة أكثر من 300 شركة. وتساعد استضافة إكسبو 2020 […]
GAZA, Israeli navy today evening opened fire at a Palestinian fishing boat sailing offshore the city of Gaza, said sources.According to one of the fishermen, Israeli boats surrounded the boat while sailing within six nautical miles offshore the city of…
SALFIT, Israeli settlers attacked today evening a surveyor while he was working in the town of Kafr Qallil to the south of Nablus, according to local sources.Sources told WAFA settlers physically attacked a 28-year-old surveying engineer, from Salfit g…
NABLUS, Two Palestinian residents of Beit Dajan town, to the east of the occupied West Bank city of Nablus, were ordered by the Israeli occupation authorities today to halt construction on their two houses, local sources said.Ghassan Daghlas, who monit…
RAMALLAH, Under the patronage and in the presence of Prime Minister Mohammed Shtayyeh, the Ministry of Local Government signed today four agreements with the Islamic Development Bank at a value of about 33 million US dollars.The agreements were signed …
